Oppi (Omeprazole)

Omeprazole, the active ingredient in Oppi, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid production and is employed to treat conditions such as gastroesophageal reflux disease, peptic ulcer disease, and erosive esophagitis in adults.

GNH USA supplies Oppi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for global healthcare providers, including bulk shipments and customized packaging solutions.

Oppi (omeprazole) is a proton pump inhibitor used to manage acid‑related gastrointestinal disorders.

- Gastroesophageal reflux disease (GERD): reduces reflux symptoms and promotes healing of esophageal irritation. - Peptic ulcer disease: promotes ulcer healing by decreasing gastric acid secretion. - Erosive esophagitis: facilitates mucosal repair and symptom relief by suppressing acid exposure.

Omeprazole may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools often transient. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild discomfort in the stomach area. - Flatulence: increased gas production. - Vomiting: occasional episodes of stomach upset. - Constipation: infrequent difficulty passing stools.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis requiring medical attention. - Acute interstitial nephritis: kidney inflammation presenting with reduced urine output. - Hypomagnesemia: low magnesium levels causing muscle cramps or arrhythmias. - Stevens‑Johnson syndrome: severe skin reaction with blistering and mucosal involvement. - Liver enzyme elevation: significant increases in ALT/AST indicating hepatic stress. - Long‑term bone fracture risk: reduced calcium absorption leading to osteoporosis with prolonged therapy.

When using Oppi, several safety considerations should be observed to minimize risks. - Assess renal function: adjust use in patients with severe kidney impairment. - Evaluate for hepatitis C infection: use with caution in active liver disease. - Monitor long‑term use: consider periodic assessment of magnesium and vitamin B12 levels. - Avoid abrupt discontinuation: taper dose if therapy has been continuous for many months to reduce rebound acid hypersecretion. - Use during pregnancy only if clearly needed: discuss risks with healthcare provider. - Store at ambient temperature: keep below 25 °C, protect from moisture and light in original packaging.

Omeprazole can affect the plasma concentrations of several concomitant medications, requiring attention to interaction potential.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, may increase cardiovascular risk. - Atazanavir: decreased antiviral exposure, may lead to treatment failure. - Methotrexate (high dose): increased toxicity due to reduced renal clearance.

Moderate Interactions (Monitor Closely): - Warfarin: possible enhancement of anticoagulant effect, monitor INR. - Digoxin: increased serum levels, observe for toxicity signs. - Phenytoin: altered metabolism, may require dose adjustment. - Iron supplements: reduced absorption, separate dosing by at least 2 hours.